Mehdi Hassaniazad

A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in<scp>COVID</scp>‐19 patients

Mehdi Hassaniazad, Ebrahim Eftekhar, Behnaz Rahnama Inchehsablagh et al. · Phytotherapy Research · 2021 · 82 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A study of factors related to patients’ length of stay using data mining techniques in a general hospital in southern Iran

Seyed Mohammad Ayyoubzadeh, Marjan Ghazisaeedi, Sharareh Rostam Niakan Kalhori et al. · Health Information Science and Systems · 2020 · 32 citations · Full text

Medicine, Biomedical Informatics, Health Informatics +16

Changes in Physiological Levels of Cortisol and Adrenocorticotropic Hormone upon Hospitalization Can Predict SARS-CoV-2 Mortality: A Cohort Study

Iraj Ahmadi, Hamideh Estabraghnia Babaki, Maryam Maleki et al. · International Journal of Endocrinology · 2022 · 31 citations · Full text

Medicine, Endocrinology, Infectious Diseases +14

Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)

Sara Mobarak, Mehdi Salasi, Ahmad Hormati et al. · Journal of Antimicrobial Chemotherapy · 2021 · 22 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Efficacy and safety of favipiravir plus interferon‐beta versus lopinavir/ritonavir plus interferon‐beta in moderately ill patients with COVID‐19: A randomized clinical trial

Mehdi Hassaniazad, Hossein Farshidi, Abdollah Gharibzadeh et al. · Journal of Medical Virology · 2022 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17